{"name":"ALX Oncology Inc.","slug":"alx-oncology-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ALX2004","genericName":"ALX2004","slug":"alx2004","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ALX2004","genericName":"ALX2004","slug":"alx2004","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxNT25TdUZndGE4ck56M3pHNmFrQUREWW51djVYSTRzeXo3bFFTNHNCQ1E0SVd5ZTh0N1ZfanNFcVpPXzhSeXBfXzJpYUhGYUZtN1FCRzNtQlcxS2xEZHpaU0ZrT0JQXzRtdmI1a2hVel9TU2NrTEpRT0Q5YU05TWZKX3ZMMDVCS2IzS0lSaFJoQmVRYlZVMjBaWTB2RlJSVlF2MmlUNENiZDZpLUVXRW01MTByWVU0NGRQUjFDOVh3MkpJWFpWRF9SNWZCQVhjLXVwZlg1NExKdzZJYVUzbFVBeDJZQ1UwUQ?oc=5","date":"2026-03-13","type":"trial","source":"The Globe and Mail","summary":"RARE's DTX301 Meets First Key Goal in Phase III OTC Deficiency Study - The Globe and Mail","headline":"RARE's DTX301 Meets First Key Goal in Phase III OTC Deficiency Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOTXBSWUVTeWZfbE82cnRUN1RjWVcyeDZRNHdGaFlyTFI5UGs5NGRrNl85TnU3NDVjb1dUU0ZhZVluUHNrallpVW1YZThsN1RZWlJ1VEx6ekI0RE1zbExsbTdfUU5vQzdqck5qZlJUTDh0aHBzQ3VEVENHTTFlaGVwS1ZNamZudHBrTjJvYmJZQUw3ck9OMWxn?oc=5","date":"2026-03-06","type":"pipeline","source":"finviz.com","summary":"Mirum Completes Enrollment & Screening in Liver Disease Studies - finviz.com","headline":"Mirum Completes Enrollment & Screening in Liver Disease Studies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPS2R4Tm4xUGZEZDcxSnk3Ym5pS2FnWmJMZ2cyQW0zNUlzUEhSTDFYNmxCTmRWeS12NVRSMTVUY2ZqQU9McHlaVEM0TTc0QXVwaVlaTVUyTUQ2SGRRSjRGSHcyc1JTc1R6bHI3NloyLTA0cG5zSUE3Yk02WGlHZzBqaHJqbWM3TTFZSTY3QlNaS1JWUThYVGM0RFJoTQ?oc=5","date":"2026-02-25","type":"pipeline","source":"Yahoo Finance","summary":"Is Teva Pharmaceutical Industries (TEVA) Outperforming Other Medical Stocks This Year? - Yahoo Finance","headline":"Is Teva Pharmaceutical Industries (TEVA) Outperforming Other Medical Stocks This Year?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxNODJvcHZzWmxBLUgyaUdRS2JqQkJ5TXp2YzhNMTNqenNySnpFRmljSk5HRkRJVV9JUFNJMW5CajUxSm00QWZiYUVIS2VaMXY0dWpneHcxTmpnbnUwdGk5cy1ZTWNoa1dSdkdCd19rVFFtazdQeU5YY2FLVjZTUHdQR1J0RW8?oc=5","date":"2026-02-09","type":"pipeline","source":"Yahoo Finance","summary":"Is ALX Oncology Holdings (ALXO) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance","headline":"Is ALX Oncology Holdings (ALXO) Stock Outpacing Its Medical Peers This Year?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPZUpSWUpHSWxobmlkWGx4WnVBZW14VFI1WWNCQ3I5OEQ5SkxyT1NuMnBKOGJidV9tbDRFMEJWRXNHUzBtVTJIWFBQcENEWm1NeldJaHRPeUJYNEFQWnJkYnB6YWdZYWJoTERTY0pXVGlTNEhYX29XMXdoVTQteFJpY0d0bmtVemh4cUo4RGw0Y1I3VTd4Q3hXX2RmMU0?oc=5","date":"2025-08-22","type":"trial","source":"curetoday.com","summary":"Various Clinical Trials in Oncology Announce Key Trial Milestones - curetoday.com","headline":"Various Clinical Trials in Oncology Announce Key Trial Milestones","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-21","type":"deal","source":"simplywall.st","summary":"Insider Buys Additional US$58k In ALX Oncology Holdings Stock - simplywall.st","headline":"Insider Buys Additional US$58k In ALX Oncology Holdings Stock","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQWWVBVkN2Q3lSa2ZKQzhTejJ3ZDM5bTdpT2psM2NTZXFIN3RMaEtsYlBodm11WmxUQk50UXJFSHEzMGs4S2Zidm90Q08td1FNVDQwbXdhSS15TGp5Szc0SDg2VVdyNUxCRUxHZzlVclM2blJ2Wmh2N3lWNXdUOGlLNUJLY0RKNXc2aGJVZi1WMlpvUERNdm8wTzg2OVdiTUhESjJWV0twZ2o?oc=5","date":"2025-08-13","type":"trial","source":"The Business Journals","summary":"Peninsula biotech company sets two clinical trials to revive its cancer-fighting fortunes - The Business Journals","headline":"Peninsula biotech company sets two clinical trials to revive its cancer-fighting fortunes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTFBEbm5mWDRSUDBYYXNmTC1Sb1FkQXB4dHF4ZnBzV1daZDhJLTN2VVM1blU1U3JGV3k1Wll1U2xEQjYyWG1sVEdRRkZiVTlORmFUOTFmQjVoRm1oMEVuejMzb3U0MTRNcDVSQzJNTF9qSHE3bWtDbjlvSVZOQVU?oc=5","date":"2025-07-07","type":"pipeline","source":"Cancer Therapy Advisor","summary":"Opinion: Top Studies From EHA 2025 - Cancer Therapy Advisor","headline":"Opinion: Top Studies From EHA 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxNZGtWZHFNbTBHS1YyTU1ENWd4Y09VQ3ZPbWQ2NmZyUHlVbl8zdU5JR1hwbl9aN2xQdlNHaWNSdWV4cjlOdEhHMGVSeEtkaWlVOFN5dGRZZHRHLUN4b1dBUmFGNGVIcWhTTi1NTnNnb00yUDlkLXRzTWVtTFZyT1ozbUtGTmxlUnZzZmEwQkZXSEVIXzR1VkxDWlluLVRXR0tDdTZteTQ0V2ZFbGM3TmJjVWM1TEI4MUlHWnRCOEwydmx6YUtreVMybWJoUWxkSkZtb3dYb1VJNjVLSTdFNWotdGY1ZnlxdnNRWkt1Q2VCeGVvbVpfUWptOXlISkhNZ01FQWF3Zks5YWVJQ0FVYkVpV2x1TnVTdVpK?oc=5","date":"2025-06-09","type":"regulatory","source":"prnewswire.com","summary":"HER2+ Gastric Cancer (including GEJ) Market to Increase at a Remarkable Growth Rate of 13% During the Study Period (2020-2034) | DelveInsight - prnewswire.com","headline":"HER2+ Gastric Cancer (including GEJ) Market to Increase at a Remarkable Growth Rate of 13% During the Study Period (2020","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiSEFVX3lxTE5MNkRCeWppSEZEZGJZN1RWMGJzYVk1T1BVYXhlS1NWNUlKYnhuYXMyQkxIWldfaW1ESXBlLVBkaXdXMDJteXRjOA?oc=5","date":"2025-05-13","type":"pipeline","source":"Intellectia AI","summary":"ALXO Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI","headline":"ALXO Stock: Price, Forecast, Financials & AI Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxOYWpMQVFsdk1PdkNuc1Ewd2xYQkVlQ2xqVmxYM0huNGkzRUlUeno3RktBaTYyZmpILUNuRXpKbDVTM0R3S3dZX1Z1LTZ6RU9KT05vdGpSam5oS0sxdHNScm5zV1RVbjJWRHJYX3BJMmZJTVJzZFBCdWI1VnhMRnNWeUNtNkZJeUUxYWc?oc=5","date":"2025-04-28","type":"trial","source":"Clinical Trials Arena","summary":"ALX Oncology’s CD47-blocker and Keytruda combo fails in two Phase II trials - Clinical Trials Arena","headline":"ALX Oncology’s CD47-blocker and Keytruda combo fails in two Phase II trials","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxONF80X2dHU3Y0TjFpSHRwQWdJT2RpbTVlY1IzS3hOZ2k5SUNFRXBzUHJDTjZxam9pVUlFQ0YyT2JDaUhTejBTcy1wN0EwOFNuUjdzZzMzSjFrc0FxaXp3dWRSdnVER1RRak1pNEhKbUl3dWQzMmoxVElnd3lscWVCMG1QNXk2UFFsajM2aw?oc=5","date":"2025-03-05","type":"trial","source":"Fierce Biotech","summary":"ALX lays off 30% of staff to pay for more trials of CD47 blocker - Fierce Biotech","headline":"ALX lays off 30% of staff to pay for more trials of CD47 blocker","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}